跳至主要内容
临床试验/EUCTR2009-017245-64-GB
EUCTR2009-017245-64-GB进行中(未招募)不适用

The effect of metformin co-treatment in hormone-replacement frozen embryo replacement cycles in women with polycystic ovary syndrome. - Metformin in frozen embryo replacement cycles in women with PCOS

eeds Teaching Hospitals NHS Trust0 个研究点目标入组 140 人开始时间: 2010年8月10日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Women who will be invited to take part in this study would be subject to following inclusion criteria:
  • Women with a known diagnosis of PCOS (as defined by the Rotterdam ESHRE/ASRM sponsored PCOS consensus workshop group, 2004)
  • Women must have cryopreserved embryos created with their own oocytes and be embarking upon their 1st FERC using this cohort of embryos
  • Women must have a normal follicular stimulating hormone (FSH) level, (ref. range 1-8.0iU/L)
  • Women must be 20-39 years of age
  • Women must have a BMI<35
  • Pre-treatment inclusion criteria would include:
  • oSerum testosterone level (< 5.0 nmol/l)
  • oNormal prolactin level (ref. range <600mU/L)
  • oNormal thyroid function test level (TSH ref. range 0.2-6.0 mIU/L)
  • oNormal renal, liver & haematological indices
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Women who do not conform to the above criteria would be excluded from the study
  • In addition to the above these specific exclusion criteria would apply:
  • Women who have had three or more failed IVF-ET cycles.
  • Women who in previous frozen embryo replacement cycles have demonstrated insufficient endometrial thickening with standard treatment doses of Progynova.
  • Women on other oral-antidiabetic agents or blood-glucose lowering preparations.
  • Women taking phenprocoumon
  • Women taking antivirals such as didanosine, stavudine, tenofovir.
  • Women taking cimetidine
  • Women taking ketofen
  • Women who have radiological examinations using contrast media within the preceding 48 hours.
  • Women with renal or hepatic impairment
  • Women who have had a recent myocardial infarct
  • Women with known vitamin B12 deficiency

研究者

发起方
eeds Teaching Hospitals NHS Trust

相似试验